||Interest Group & Committee
|Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest Groups
||POCT & Quality Indicators SIG
||Clinical Chemistry and Laboratory Medicine (CCLM), Volume 61, Issue 7, Pages 1280-1287.
|Reduce, Reuse, Recycle: Top 10 Choosing Wisely Canada’s Recommendations for Conserving Laboratory Resources
||Utilization Management SIG
||Canadian Journal General Internal Medicine, Volume 17, Issue 4, Pages 86-95.
|Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of 2021 Canadian Cardiovascular Society Lipid Guidelines
||Harmonization of Reference Interval Working Group
||Canadian Journal of Cardiology, Volume 38, Issue 8, Pages 1180-1188.
|Intrapartum Fetal Scalp Lactate Testing: Considerations for Implementation and Clinical Decision Making
||J OBstet Gynaecol Can., Volume 43, Issue 11, Pages 1244-1246.
|Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection, and quality management of SARS-CoV-2 point-of-care tests
||Clinical Biochemistry, Volume 95, Pages 1-12.
|AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory Developed Test Serologic Testing in Clinical Laboratories
||Clinical Chemistry, Volume 67, Issue 9, Pages 1188-1200.
|Quality assurance practices for point of care testing programs: Recommendations by the Canadian society of clinical chemists point of care testing interest group
||Clinical Biochemistry, Volume 88, Pages 11-17.
|Canadian Society of Clinical Chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology
||Clinical Biochemistry, Volume 86, Pages 1-7.
|Interim guidance on the use of the Abbott ID NOWTM instrument and COVID-19 assay on behalf of the Canadian Public Health Laboratory Network and the Canadian Society of Clinical Chemists
||Can Commun Dis Rep, Volume 46, Issue 11/12, Pages 422-426.
|Point-of-care testing: A position statement from the Canadian Society of Clinical Chemists
||Clinical Biochemistry, Volume 53, Pages 156-159.
|Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working Group
||Monoclonal Gammopathy SIG
||Clinical Biochemistry, Volume 51, Pages 10-20.
|Cardiac troponin testing in the acute care setting: Ordering, reporting, and high sensitivity assays – an update from the Canadian Society of Clinical Chemists (CSCC)
||Clinical Biochemistry, Volume 44, Issue 16, Pages 1273 – 1277.